This record is a partial extract of the original cable. The full text of the original cable is not available.

UNCLAS BRASILIA 000757 
 
SIPDIS 
 
PLS PASS USTR FOR SCRONIN 
USDOC FOR 3134/USFCS/OIO/WH/EOLSON 
USDOC FOR 4332/ITA/MAC/WH/OLAC/MWARD 
STATE FOR WHA/BSC DAVID EDWARDS AND EB/TPP/MTA/MST ANDREW 
DILWORTH 
 
E.O. 12958: N/A 
TAGS: ETRD ECON BR
SUBJECT: NOTIFICATION OF SUSPENSION OF ANTI-DUMPING MEASURES ON 
INSULIN 
 
 
¶1. Post received a letter dated March 7, 2005 from the 
Department of Trade Defense of the Ministry of Development, 
Industry and Foreign Trade, notifying the USG of Brazil's 
intention to suspend anti-dumping measures for one year 
concerning exports to Brazil of medicines containing insulin 
originating from Denmark, France and the U.S.  An unofficial 
translation of the text of the letter follows in paragraph 2. 
Original will be filed at Post. 
 
¶2. Start Text. 
Note no. 499/DECOM/CGAP 
 
Rio de Janeiro, March 7, 2005 
 
Ambassador, 
 
In accordance with article 61, sole paragraph, of Decree 
no. 1.602 of 1995, we are notifying the U.S. Embassy that 
the Chamber of Foreign Trade (CAMEX), by means of 
Resolution no. 4, published in today's Diario Oficial da 
Uniao (DOU), decided to suspend for one year antidumping 
measures applied to importation of medicines containing 
insulin, originating from Denmark, France, and the U.S.A., 
based on art. 60 of Decree no. 1602 of August 23, 1995. 
The anti-dumping order had been established through CAMEX 
Resolution no. 2 of February 23, 2001. 
 
I am attaching a copy of said Resolution in accordance with 
the recommendations of Art. 60 of the cited Decree. 
 
Finally, we request that you notify the U.S. firm ELI LILLY 
AND COMPANY, INC. regarding the decision contained in CAMEX 
Resolution no. 4 of 2005. 
 
(signed Armando de Mello Meziat) 
Director of Department of Trade Defense 
End Text. 
 
DANILOVICH